Name | BDTX-189 |
---|
Description | BDTX-189 is a potent, orally active and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations, includes EGFR/HER2 exon 20 insertion mutants. BDTX-189 shows KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively. Anticancer activity. |
---|
Molecular Formula | C29H29ClN6O4 |
---|---|
Molecular Weight | 561.03 |
Storage condition | -20°C |